awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28075305-BBF5AA08-E2A1-42BF-A49B-B9C7958234F5
Q28075305-BBF5AA08-E2A1-42BF-A49B-B9C7958234F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075305-BBF5AA08-E2A1-42BF-A49B-B9C7958234F5
Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma
P2860
Q28075305-BBF5AA08-E2A1-42BF-A49B-B9C7958234F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075305-BBF5AA08-E2A1-42BF-A49B-B9C7958234F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53dbb7e0c063904e0eff269df609ba4e8038f92f
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.